33. STUDYING THE MEMORY ENHANCING EFFECT OF HUP A SOFT CAPSULE USING TRIMETHYLTIN CHLORIDE MODEL ON MICE

Le Thi Hong Hanh1, Do Minh Trung2, Trinh Nam Trung1, Nguyen Thuy Linh3, Nguyen Van Thu1
1 Pharmacy Training Institute, Military Medical University
2 Military Medical and Pharmaceutical Research Institute, Military Medical University
3 103 Military Hospital

Main Article Content

Abstract

Objective: Evaluating the memory enhancing effect of Hup A soft capsules using the Trimethyltin chloride (TMT) model on mice.


Method: The product used in the study is Hup A soft capsule that met Enterprise standard, mice were given Hup A at doses of 192mg/kg/24h and 384mg/kg/24h, then injected peritoneal with Trimethyltin chloride (TMT) at 2,4mg/kg/24h. Mice were tested on the Bold Hold and the Automatic Conditioned Reflex machine. Mice were monitored for the following indicators: the total number of times the mouse stuck its head into the hole within 5 minutes and the total number of times the mouse responded to avoid electric shock, and observed mouse brain histopathology.


Results: Compared to the TMT group, these Hup A groups increased the number of times these animals stuck their heads into the hole, but there was no difference (p >0.05). However, these Hup A groups increased the number of times these animals avoided electric shock and showed less damage in brain histology than the TMT group.


Conclusion: Our study showed that Hup A soft capsules enhance memory by increasing natural exploration activities, reducing anxiety, increasing the ability to avoid electric shock, and reducing brain tissue damage in mice caused by TMT.

Article Details

References

[1] Hardy J Lane CA, Schott JM, Alzheimer’s
disease. Eur J Neurol, 25(1) 59-70, 2018.
[2] Kivipelto M Qiu C, von Strauss E, Epidemiology
of Alzheimer’s disease: occurrence, determinants,
and strategies toward intervention. Dialogues
Clin Neurosci, 11(2): 111-128, 2009.
[3] SH Xing, CX Zhu, R Zhang et al., Huperzine
a in the treatment of Alzheimer’s disease and
vascular dementia: a meta-analysis. Evid Based
Complement Alternat Med, 2014: 363985.
[4] HY Zhang, New insights into huperzine A for
the treatment of Alzheimer’s disease. Acta
Pharmacol Sin, 33(9): 1170-5, 2012.
[5] Geloso MC, V Corvino, F Michetti, Trimethyltininduced
hippocampal degeneration as a tool
to investigate neurodegenerative processes.
Neurochem Int, 2011. 58(7): p. 729-38.
[6] Casarrubea M et al., The hole-board apparatus in
the study of anxiety. Physiol Behav, 2023, 271:
p. 114346.
[7] Zhang H et al., Huperzine-A Improved Animal
Behavior in Cuprizone-Induced Mouse
Model by Alleviating Demyelination and
Neuroinflammation. Int J Mol Sci, 2022, 23(24).
[8] Yuta YTO, Mitsue I, JapaneseHuperzia
serrataextract and the constituent, huperzine A,
amelioratethe scopolamine-induced cognitive
impairment in mice. Bioscience, Biotechnology,
and Biochemistry, Vol. 79, No. 11, 2015, 1838–
1844: 1838-184.